Anti-chrondrosarcoma compounds
US7189700B2 · kind B2 · utility
1Cited by
21References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 20, 2003 |
| Grant date | Mar 13, 2007 |
| Priority date | — |
| Expiry date | Jun 29, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides inhibitors of chondrosarcoma cell growth that are useful as anti-cancer and anti-tumor agents. The inhibitors are peptides having sequences related to cleavage regions of the proenzyme forms of matrix metalloproteinases and that can inhibit the activity of matrix metalloproteinases. The peptide inhibitors of the invention can be formulated into therapeutic compositions, lotions, creams and wound dressings.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.